CPIX: Cumberland Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 24.24
Enterprise Value ($M) 18.36
Book Value ($M) 29.26
Book Value / Share 2.06
Price / Book 0.83
NCAV ($M) -16.80
NCAV / Share -1.19
Price / NCAV -1.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.07
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 1.11
Current Ratio 1.28

Balance Sheet (mrq) ($M)
Current Assets 35.71
Assets 81.78
Liabilities 52.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 39.55
Operating Income -9.55
Net Income -6.28
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 6.09
Cash from Investing -0.11
Cash from Financing -7.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-09 13G Cumberland Pharmaceuticals Inc 40.14 -1.24

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K ____________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 121 4,367 2.77
2024-03-26 1,735 11,264 15.40
2024-03-25 213 12,493 1.70
2024-03-22 4,714 21,653 21.77

(click for more detail)

Similar Companies
CGON – CG Oncology, Inc. COGT – Cogent Biosciences, Inc.
COLL – Collegium Pharmaceutical, Inc. CRBU – Caribou Biosciences, Inc.
CRGX – CARGO Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io